SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5mov'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RU9_H_ACTH611_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 6	LEU A 249 TRP A 281 LEU A 301 PHE A 232	None	1.41A	1ru9H-5movA: undetectable 1ru9L-5movA: undetectable	1ru9H-5movA: 20.30 1ru9L-5movA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RUK_L_ACTL611_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 6	LEU A 249 TRP A 281 LEU A 301 PHE A 232	None	1.47A	1rukH-5movA: undetectable 1rukL-5movA: undetectable	1rukH-5movA: 20.30 1rukL-5movA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	HIS A 154 LEU A 85 ILE A 174 MET A 163 PHE A 113	None None HC4 A 401 ( 3.7A) HC4 A 401 ( 4.0A) HC4 A 401 (-3.4A)	1.49A	1xlxA-5movA: undetectable	1xlxA-5movA: 24.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	HIS A 154 LEU A 85 ILE A 174 MET A 163 PHE A 113	None None HC4 A 401 ( 3.7A) HC4 A 401 ( 4.0A) HC4 A 401 (-3.4A)	1.44A	1xomA-5movA: undetectable	1xomA-5movA: 22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	HIS A 154 LEU A 85 ILE A 174 MET A 163 PHE A 113	None None HC4 A 401 ( 3.7A) HC4 A 401 ( 4.0A) HC4 A 401 (-3.4A)	1.43A	1xomB-5movA: undetectable	1xomB-5movA: 22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EUF_B_LQQB401_1 (CELL DIVISION PROTEIN KINASE 6)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	6 / 12	VAL A 53 LYS A 68 PHE A 113 VAL A 116 ASN A 161 ASP A 175	None HC4 A 401 (-2.7A) HC4 A 401 (-3.4A) None None HC4 A 401 (-4.0A)	0.61A	2eufB-5movA: 30.0	2eufB-5movA: 29.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_A_MIXA539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 12	LEU A 45 VAL A 53 ASP A 156 LYS A 158 ASN A 161 MET A 163 ASP A 175	HC4 A 401 ( 4.8A) None None None None HC4 A 401 ( 4.0A) HC4 A 401 (-4.0A)	0.88A	2fumA-5movA: 24.6	2fumA-5movA: 25.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_D_MIXD3539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 12	LEU A 45 GLY A 46 GLY A 48 VAL A 53 LYS A 158 ASN A 161 MET A 163	HC4 A 401 ( 4.8A) None None None None None HC4 A 401 ( 4.0A)	0.95A	2fumD-5movA: 23.0	2fumD-5movA: 25.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IVU_A_ZD6A3015_0 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 12	LEU A 45 GLY A 46 VAL A 53 LYS A 68 LEU A 85 LEU A 111 ASP A 175	HC4 A 401 ( 4.8A) None None HC4 A 401 (-2.7A) None None HC4 A 401 (-4.0A)	0.80A	2ivuA-5movA: 24.2	2ivuA-5movA: 23.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IVU_A_ZD6A3015_0 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 12	LEU A 45 VAL A 53 LYS A 68 GLU A 81 LEU A 85 LEU A 111 ASP A 175	HC4 A 401 ( 4.8A) None HC4 A 401 (-2.7A) None None None HC4 A 401 (-4.0A)	0.92A	2ivuA-5movA: 24.2	2ivuA-5movA: 23.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OZ7_A_CA4A1_1 (ANDROGEN RECEPTOR)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	LEU A 128 VAL A 327 ARG A 169 ALA A 297 LEU A 301	None	1.12A	2oz7A-5movA: undetectable	2oz7A-5movA: 22.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VAV_F_CSCF1383_2 (ACETYL-COA--DEACETYL CEPHALOSPORIN C ACETYLTRANSFERASE)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	LEU A 213 MET A 153 MET A 137	None	0.71A	2vavF-5movA: undetectable	2vavF-5movA: 20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3C6G_A_VD3A701_1 (CYTOCHROME P450 2R1)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	LEU A 41 ALA A 56 ALA A 110 GLY A 34 ILE A 59	None	1.01A	3c6gA-5movA: undetectable	3c6gA-5movA: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3D91_A_REMA350_1 (RENIN)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	GLN A 40 GLY A 34 THR A 60 ASP A 99 ALA A 98	None	1.25A	3d91A-5movA: undetectable	3d91A-5movA: 22.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	HIS A 154 LEU A 85 ILE A 174 MET A 163 PHE A 113	None None HC4 A 401 ( 3.7A) HC4 A 401 ( 4.0A) HC4 A 401 (-3.4A)	1.41A	3g4lB-5movA: undetectable	3g4lB-5movA: 23.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WAR_A_NIOA401_1 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	8 / 8	VAL A 53 VAL A 66 LYS A 68 ILE A 95 PHE A 113 MET A 163 ILE A 174 ASP A 175	None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 ( 4.5A) HC4 A 401 (-3.4A) HC4 A 401 ( 4.0A) HC4 A 401 ( 3.7A) HC4 A 401 (-4.0A)	0.28A	3warA-5movA: 41.3	3warA-5movA: 96.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AQL_A_TXCA1452_2 (GUANINE DEAMINASE)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 5	HIS A 148 LEU A 305 LEU A 222 ASP A 302	None	1.00A	4aqlA-5movA: undetectable	4aqlA-5movA: 20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E7B_C_ACTC513_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	TYR A 196 HIS A 234 ARG A 195	None	1.07A	4e7bC-5movA: undetectable	4e7bC-5movA: 21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FUB_A_ACTA311_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	TYR A 196 ARG A 244 HIS A 236	None	1.25A	4fubA-5movA: undetectable	4fubA-5movA: 20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OLT_A_GCSA303_1 (CHITOSANASE)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 6	ILE A 133 ARG A 228 VAL A 285 HIS A 291	None	0.90A	4oltA-5movA: undetectable	4oltA-5movA: 20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OLT_B_GCSB303_1 (CHITOSANASE)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 6	ILE A 133 ARG A 228 VAL A 285 HIS A 291	None	0.85A	4oltB-5movA: undetectable	4oltB-5movA: 20.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CSH_B_ACTB401_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 5	ARG A 80 ARG A 155 LEU A 178 ASN A 189 VAL A 192	None	0.20A	5cshB-5movA: 50.1	5cshB-5movA: 92.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CU6_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG A 80 ARG A 155 LEU A 178 ASN A 189	None	0.00A	5cu6A-5movA: 52.2	5cu6A-5movA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CU6_A_ACTA403_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	6 / 6	TYR A 39 ILE A 69 VAL A 101 ASP A 103 PRO A 104 ALA A 110	None	0.22A	5cu6A-5movA: 52.2	5cu6A-5movA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CVF_A_ACTA403_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG A 80 ARG A 155 LEU A 178 ASN A 189	None	0.00A	5cvfA-5movA: 52.0	5cvfA-5movA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OS7_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG A 80 ARG A 155 LEU A 178 ASN A 189	None	0.15A	5os7A-5movA: 50.7	5os7A-5movA: 92.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OS7_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	HIS A 276 SER A 277 LYS A 279	None	0.36A	5os7A-5movA: 50.7	5os7A-5movA: 92.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OS7_B_ACTB401_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 5	ARG A 80 ARG A 155 LEU A 178 ASN A 189 VAL A 192	None	0.11A	5os7B-5movA: 50.7	5os7B-5movA: 92.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OS8_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 5	LYS A 77 ARG A 80 ARG A 155 LEU A 178 ASN A 189	None	0.37A	5os8A-5movA: 52.0	5os8A-5movA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OSP_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG A 80 ARG A 155 LEU A 178 ASN A 189	None	0.00A	5ospA-5movA: 52.2	5ospA-5movA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OSR_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 5	ARG A 80 ARG A 155 LEU A 178 ASN A 189	None	0.00A	5osrA-5movA: 51.6	5osrA-5movA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OSR_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 7	TYR A 39 VAL A 67 ILE A 69 VAL A 101 ASP A 103 PRO A 104 ALA A 110	None	0.18A	5osrA-5movA: 51.6	5osrA-5movA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OTR_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 5	ARG A 80 ARG A 155 LEU A 178 ASN A 189	None	0.08A	5otrA-5movA: 50.8	5otrA-5movA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OTR_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 5	TYR A 39 VAL A 101 ASP A 103 PRO A 104 ALA A 110	None	0.00A	5otrA-5movA: 50.8	5otrA-5movA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_G_CVIG301_1 (REGULATORY PROTEIN TETR)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 7	GLY A 185 TYR A 257 ASP A 210 TYR A 211	None	1.14A	5vlmG-5movA: undetectable	5vlmG-5movA: 17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9M_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 8	LEU A 45 VAL A 53 VAL A 66 LYS A 68 ASP A 175	HC4 A 401 ( 4.8A) None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 (-4.0A)	0.74A	5y9mX-5movA: 48.4	5y9mX-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9M_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	6 / 8	VAL A 53 VAL A 66 LYS A 68 MET A 163 ILE A 174 ASP A 175	None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 ( 4.0A) HC4 A 401 ( 3.7A) HC4 A 401 (-4.0A)	0.67A	5y9mX-5movA: 48.4	5y9mX-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5Y9M_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	6 / 8	VAL A 53 VAL A 66 LYS A 68 PHE A 113 ILE A 174 ASP A 175	None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 (-3.4A) HC4 A 401 ( 3.7A) HC4 A 401 (-4.0A)	0.25A	5y9mX-5movA: 48.4	5y9mX-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_B_NIOB401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 7	VAL A 53 VAL A 66 LYS A 68 PHE A 113 ILE A 95	None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 (-3.4A) HC4 A 401 ( 4.5A)	1.39A	5yf9B-5movA: 34.8	5yf9B-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_B_NIOB401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 7	VAL A 53 VAL A 66 LYS A 68 PHE A 113 MET A 163 ILE A 174 ASP A 175	None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 (-3.4A) HC4 A 401 ( 4.0A) HC4 A 401 ( 3.7A) HC4 A 401 (-4.0A)	0.68A	5yf9B-5movA: 34.8	5yf9B-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	6 / 9	LEU A 45 VAL A 53 VAL A 66 LYS A 68 PHE A 113 ASP A 175	HC4 A 401 ( 4.8A) None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 (-3.4A) HC4 A 401 (-4.0A)	0.69A	5yf9X-5movA: 48.2	5yf9X-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 9	LEU A 45 VAL A 66 LYS A 68 ILE A 174 PHE A 113	HC4 A 401 ( 4.8A) HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 ( 3.7A) HC4 A 401 (-3.4A)	1.24A	5yf9X-5movA: 48.2	5yf9X-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 9	VAL A 53 VAL A 66 LYS A 68 ILE A 95 PHE A 113 ILE A 174 ASP A 175	None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 ( 4.5A) HC4 A 401 (-3.4A) HC4 A 401 ( 3.7A) HC4 A 401 (-4.0A)	0.27A	5yf9X-5movA: 48.2	5yf9X-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YF9_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 9	VAL A 53 VAL A 66 LYS A 68 PHE A 113 MET A 163 ILE A 174 ASP A 175	None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 (-3.4A) HC4 A 401 ( 4.0A) HC4 A 401 ( 3.7A) HC4 A 401 (-4.0A)	0.64A	5yf9X-5movA: 48.2	5yf9X-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YWM_X_NIOX403_0 (CASEIN KINASE II SUBUNIT ALPHA')	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 7	VAL A 53 VAL A 66 LYS A 68 ILE A 95 PHE A 113 ILE A 174 ASP A 175	None HC4 A 401 (-4.4A) HC4 A 401 (-2.7A) HC4 A 401 ( 4.5A) HC4 A 401 (-3.4A) HC4 A 401 ( 3.7A) HC4 A 401 (-4.0A)	0.33A	5ywmX-5movA: 47.3	5ywmX-5movA: 25.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZV2_A_LEVA801_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 1)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	LYS A 77 LEU A 85 ASP A 175	None None HC4 A 401 (-4.0A)	0.89A	5zv2A-5movA: 20.1	5zv2A-5movA: 12.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BXN_B_SAMB901_0 (DIPHTHAMIDE BIOSYNTHESIS ENZYME DPH2)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	PHE A 232 GLY A 235 HIS A 236 ARG A 244 ILE A 245	None	1.33A	6bxnB-5movA: undetectable	6bxnB-5movA: 21.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6GMD_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 5	ARG A 80 ARG A 155 LEU A 178 ASN A 189 VAL A 192	None	0.11A	6gmdA-5movA: 50.7	6gmdA-5movA: 92.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6GMD_B_ACTB401_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG A 80 ARG A 155 LEU A 178 ASN A 189	None	0.15A	6gmdB-5movA: 50.6	6gmdB-5movA: 92.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6GMD_B_ACTB402_0 (CASEIN KINASE II SUBUNIT ALPHA)	5mov	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	HIS A 276 SER A 277 LYS A 279	None	0.36A	6gmdB-5movA: 50.6	6gmdB-5movA: 92.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1RU9_H_ACTH611_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"LEU A 249;TRP A 281;LEU A 301;PHE A 232","None","1.41A","1ru9H-5movA:undetectable;1ru9L-5movA:undetectable","1ru9H-5movA:20.30;1ru9L-5movA:19.38"],["1RUK_L_ACTL611_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"LEU A 249;TRP A 281;LEU A 301;PHE A 232","None","1.47A","1rukH-5movA:undetectable;1rukL-5movA:undetectable","1rukH-5movA:20.30;1rukL-5movA:19.38"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"HIS A 154;LEU A  85;ILE A 174;MET A 163;PHE A 113","None;None;HC4 A 401 ( 3.7A);HC4 A 401 ( 4.0A);HC4 A 401 (-3.4A)","1.49A","1xlxA-5movA:undetectable","1xlxA-5movA:24.52"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"HIS A 154;LEU A  85;ILE A 174;MET A 163;PHE A 113","None;None;HC4 A 401 ( 3.7A);HC4 A 401 ( 4.0A);HC4 A 401 (-3.4A)","1.44A","1xomA-5movA:undetectable","1xomA-5movA:22.86"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"HIS A 154;LEU A  85;ILE A 174;MET A 163;PHE A 113","None;None;HC4 A 401 ( 3.7A);HC4 A 401 ( 4.0A);HC4 A 401 (-3.4A)","1.43A","1xomB-5movA:undetectable","1xomB-5movA:22.86"],["2EUF_B_LQQB401_1","CELL DIVISION PROTEIN KINASE 6","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",6,"VAL A  53;LYS A  68;PHE A 113;VAL A 116;ASN A 161;ASP A 175","None;HC4 A 401 (-2.7A);HC4 A 401 (-3.4A);None;None;HC4 A 401 (-4.0A)","0.61A","2eufB-5movA:30.0","2eufB-5movA:29.65"],["2FUM_A_MIXA539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"LEU A  45;VAL A  53;ASP A 156;LYS A 158;ASN A 161;MET A 163;ASP A 175","HC4 A 401 ( 4.8A);None;None;None;None;HC4 A 401 ( 4.0A);HC4 A 401 (-4.0A)","0.88A","2fumA-5movA:24.6","2fumA-5movA:25.22"],["2FUM_D_MIXD3539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"LEU A  45;GLY A  46;GLY A  48;VAL A  53;LYS A 158;ASN A 161;MET A 163","HC4 A 401 ( 4.8A);None;None;None;None;None;HC4 A 401 ( 4.0A)","0.95A","2fumD-5movA:23.0","2fumD-5movA:25.22"],["2IVU_A_ZD6A3015_0","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"LEU A  45;GLY A  46;VAL A  53;LYS A  68;LEU A  85;LEU A 111;ASP A 175","HC4 A 401 ( 4.8A);None;None;HC4 A 401 (-2.7A);None;None;HC4 A 401 (-4.0A)","0.80A","2ivuA-5movA:24.2","2ivuA-5movA:23.35"],["2IVU_A_ZD6A3015_0","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET PRECURSOR","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"LEU A  45;VAL A  53;LYS A  68;GLU A  81;LEU A  85;LEU A 111;ASP A 175","HC4 A 401 ( 4.8A);None;HC4 A 401 (-2.7A);None;None;None;HC4 A 401 (-4.0A)","0.92A","2ivuA-5movA:24.2","2ivuA-5movA:23.35"],["2OZ7_A_CA4A1_1","ANDROGEN RECEPTOR","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"LEU A 128;VAL A 327;ARG A 169;ALA A 297;LEU A 301","None","1.12A","2oz7A-5movA:undetectable","2oz7A-5movA:22.09"],["2VAV_F_CSCF1383_2","ACETYL-COA--DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"LEU A 213;MET A 153;MET A 137","None","0.71A","2vavF-5movA:undetectable","2vavF-5movA:20.45"],["3C6G_A_VD3A701_1","CYTOCHROME P450 2R1","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"LEU A  41;ALA A  56;ALA A 110;GLY A  34;ILE A  59","None","1.01A","3c6gA-5movA:undetectable","3c6gA-5movA:22.90"],["3D91_A_REMA350_1","RENIN","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"GLN A  40;GLY A  34;THR A  60;ASP A  99;ALA A  98","None","1.25A","3d91A-5movA:undetectable","3d91A-5movA:22.31"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"HIS A 154;LEU A  85;ILE A 174;MET A 163;PHE A 113","None;None;HC4 A 401 ( 3.7A);HC4 A 401 ( 4.0A);HC4 A 401 (-3.4A)","1.41A","3g4lB-5movA:undetectable","3g4lB-5movA:23.43"],["3WAR_A_NIOA401_1","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",8,"VAL A  53;VAL A  66;LYS A  68;ILE A  95;PHE A 113;MET A 163;ILE A 174;ASP A 175","None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 ( 4.5A);HC4 A 401 (-3.4A);HC4 A 401 ( 4.0A);HC4 A 401 ( 3.7A);HC4 A 401 (-4.0A)","0.28A","3warA-5movA:41.3","3warA-5movA:96.69"],["4AQL_A_TXCA1452_2","GUANINE DEAMINASE","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"HIS A 148;LEU A 305;LEU A 222;ASP A 302","None","1.00A","4aqlA-5movA:undetectable","4aqlA-5movA:20.04"],["4E7B_C_ACTC513_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"TYR A 196;HIS A 234;ARG A 195","None","1.07A","4e7bC-5movA:undetectable","4e7bC-5movA:21.31"],["4FUB_A_ACTA311_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"TYR A 196;ARG A 244;HIS A 236","None","1.25A","4fubA-5movA:undetectable","4fubA-5movA:20.62"],["4OLT_A_GCSA303_1","CHITOSANASE","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ILE A 133;ARG A 228;VAL A 285;HIS A 291","None","0.90A","4oltA-5movA:undetectable","4oltA-5movA:20.61"],["4OLT_B_GCSB303_1","CHITOSANASE","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ILE A 133;ARG A 228;VAL A 285;HIS A 291","None","0.85A","4oltB-5movA:undetectable","4oltB-5movA:20.61"],["5CSH_B_ACTB401_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ARG A  80;ARG A 155;LEU A 178;ASN A 189;VAL A 192","None","0.20A","5cshB-5movA:50.1","5cshB-5movA:92.00"],["5CU6_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG A  80;ARG A 155;LEU A 178;ASN A 189","None","0.00A","5cu6A-5movA:52.2","5cu6A-5movA:100.00"],["5CU6_A_ACTA403_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",6,"TYR A  39;ILE A  69;VAL A 101;ASP A 103;PRO A 104;ALA A 110","None","0.22A","5cu6A-5movA:52.2","5cu6A-5movA:100.00"],["5CVF_A_ACTA403_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG A  80;ARG A 155;LEU A 178;ASN A 189","None","0.00A","5cvfA-5movA:52.0","5cvfA-5movA:100.00"],["5OS7_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG A  80;ARG A 155;LEU A 178;ASN A 189","None","0.15A","5os7A-5movA:50.7","5os7A-5movA:92.00"],["5OS7_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"HIS A 276;SER A 277;LYS A 279","None","0.36A","5os7A-5movA:50.7","5os7A-5movA:92.00"],["5OS7_B_ACTB401_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ARG A  80;ARG A 155;LEU A 178;ASN A 189;VAL A 192","None","0.11A","5os7B-5movA:50.7","5os7B-5movA:92.00"],["5OS8_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"LYS A  77;ARG A  80;ARG A 155;LEU A 178;ASN A 189","None","0.37A","5os8A-5movA:52.0","5os8A-5movA:100.00"],["5OSP_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG A  80;ARG A 155;LEU A 178;ASN A 189","None","0.00A","5ospA-5movA:52.2","5ospA-5movA:100.00"],["5OSR_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG A  80;ARG A 155;LEU A 178;ASN A 189","None","0.00A","5osrA-5movA:51.6","5osrA-5movA:100.00"],["5OSR_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"TYR A  39;VAL A  67;ILE A  69;VAL A 101;ASP A 103;PRO A 104;ALA A 110","None","0.18A","5osrA-5movA:51.6","5osrA-5movA:100.00"],["5OTR_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG A  80;ARG A 155;LEU A 178;ASN A 189","None","0.08A","5otrA-5movA:50.8","5otrA-5movA:100.00"],["5OTR_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"TYR A  39;VAL A 101;ASP A 103;PRO A 104;ALA A 110","None","0.00A","5otrA-5movA:50.8","5otrA-5movA:100.00"],["5VLM_G_CVIG301_1","REGULATORY PROTEIN TETR","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"GLY A 185;TYR A 257;ASP A 210;TYR A 211","None","1.14A","5vlmG-5movA:undetectable","5vlmG-5movA:17.90"],["5Y9M_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"LEU A  45;VAL A  53;VAL A  66;LYS A  68;ASP A 175","HC4 A 401 ( 4.8A);None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 (-4.0A)","0.74A","5y9mX-5movA:48.4","5y9mX-5movA:25.96"],["5Y9M_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",6,"VAL A  53;VAL A  66;LYS A  68;MET A 163;ILE A 174;ASP A 175","None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 ( 4.0A);HC4 A 401 ( 3.7A);HC4 A 401 (-4.0A)","0.67A","5y9mX-5movA:48.4","5y9mX-5movA:25.96"],["5Y9M_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",6,"VAL A  53;VAL A  66;LYS A  68;PHE A 113;ILE A 174;ASP A 175","None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 (-3.4A);HC4 A 401 ( 3.7A);HC4 A 401 (-4.0A)","0.25A","5y9mX-5movA:48.4","5y9mX-5movA:25.96"],["5YF9_B_NIOB401_1","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"VAL A  53;VAL A  66;LYS A  68;PHE A 113;ILE A  95","None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 (-3.4A);HC4 A 401 ( 4.5A)","1.39A","5yf9B-5movA:34.8","5yf9B-5movA:25.96"],["5YF9_B_NIOB401_1","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"VAL A  53;VAL A  66;LYS A  68;PHE A 113;MET A 163;ILE A 174;ASP A 175","None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 (-3.4A);HC4 A 401 ( 4.0A);HC4 A 401 ( 3.7A);HC4 A 401 (-4.0A)","0.68A","5yf9B-5movA:34.8","5yf9B-5movA:25.96"],["5YF9_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",6,"LEU A  45;VAL A  53;VAL A  66;LYS A  68;PHE A 113;ASP A 175","HC4 A 401 ( 4.8A);None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 (-3.4A);HC4 A 401 (-4.0A)","0.69A","5yf9X-5movA:48.2","5yf9X-5movA:25.96"],["5YF9_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"LEU A  45;VAL A  66;LYS A  68;ILE A 174;PHE A 113","HC4 A 401 ( 4.8A);HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 ( 3.7A);HC4 A 401 (-3.4A)","1.24A","5yf9X-5movA:48.2","5yf9X-5movA:25.96"],["5YF9_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"VAL A  53;VAL A  66;LYS A  68;ILE A  95;PHE A 113;ILE A 174;ASP A 175","None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 ( 4.5A);HC4 A 401 (-3.4A);HC4 A 401 ( 3.7A);HC4 A 401 (-4.0A)","0.27A","5yf9X-5movA:48.2","5yf9X-5movA:25.96"],["5YF9_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"VAL A  53;VAL A  66;LYS A  68;PHE A 113;MET A 163;ILE A 174;ASP A 175","None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 (-3.4A);HC4 A 401 ( 4.0A);HC4 A 401 ( 3.7A);HC4 A 401 (-4.0A)","0.64A","5yf9X-5movA:48.2","5yf9X-5movA:25.96"],["5YWM_X_NIOX403_0","CASEIN KINASE II SUBUNIT ALPHA'","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"VAL A  53;VAL A  66;LYS A  68;ILE A  95;PHE A 113;ILE A 174;ASP A 175","None;HC4 A 401 (-4.4A);HC4 A 401 (-2.7A);HC4 A 401 ( 4.5A);HC4 A 401 (-3.4A);HC4 A 401 ( 3.7A);HC4 A 401 (-4.0A)","0.33A","5ywmX-5movA:47.3","5ywmX-5movA:25.96"],["5ZV2_A_LEVA801_2","FIBROBLAST GROWTH FACTOR RECEPTOR 1","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"LYS A  77;LEU A  85;ASP A 175","None;None;HC4 A 401 (-4.0A)","0.89A","5zv2A-5movA:20.1","5zv2A-5movA:12.93"],["6BXN_B_SAMB901_0","DIPHTHAMIDE BIOSYNTHESIS ENZYME DPH2","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"PHE A 232;GLY A 235;HIS A 236;ARG A 244;ILE A 245","None","1.33A","6bxnB-5movA:undetectable","6bxnB-5movA:21.49"],["6GMD_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ARG A  80;ARG A 155;LEU A 178;ASN A 189;VAL A 192","None","0.11A","6gmdA-5movA:50.7","6gmdA-5movA:92.00"],["6GMD_B_ACTB401_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG A  80;ARG A 155;LEU A 178;ASN A 189","None","0.15A","6gmdB-5movA:50.6","6gmdB-5movA:92.00"],["6GMD_B_ACTB402_0","CASEIN KINASE II SUBUNIT ALPHA","5mov","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"HIS A 276;SER A 277;LYS A 279","None","0.36A","6gmdB-5movA:50.6","6gmdB-5movA:92.00"]]